Who is the registered owner or corporate officer of Neurocept in U.S. business filings?
Executive summary
Available reporting provided for review does not include any U.S. business filings for an entity named “Neurocept,” so this analysis cannot identify a registered owner or corporate officer from those sources; instead, it explains the gap, highlights potential confusion with similarly named companies in the neuroscience sector (Neuropace, Neuronetics, NeuroOne, Neurocrine), and points to the public records and searches that would reliably answer the question (state Secretary of State records, SEC filings, registered‑agent filings) [1] [2] [3] [4] [5].
1. The question asked and the limits of the provided reporting
The user seeks the registered owner or corporate officer of “Neurocept” as shown in U.S. business filings, but none of the supplied sources contain a business filing, corporate record, or officer list for an entity by that name; the dataset instead includes SEC or investor pages for other companies (Neuropace, Neuronetics, NeuroOne, Neurocrine) and general filing resources, so a direct identification cannot be made from these materials [1] [2] [3] [4].
2. Why similar names matter — common pitfalls when searching corporate records
Neuroscience and neurotech company names often overlap or sound similar, and the search snippets supplied include corporate filings for Neuropace, Neuronetics, NeuroOne and Neurocrine — each with SEC/investor pages or state filing references — illustrating how one can mistakenly conflate separate entities when hunting for “Neurocept” in public records [1] [2] [3] [4].
3. Where the definitive answers live: state registries and SEC filings
Official, authoritative ownership and officer information is recorded at the state level in Secretary of State business entity filings and, when applicable, in SEC filings for public companies; the California Secretary of State’s Business Entities portal and similar state registries are explicit repositories for statements of information, officer names and registered agents, and they process and publish more than a hundred filing types online [5].
4. Practical next steps to locate Neurocept’s registered owner or officer
To obtain the registered owner or corporate officers for Neurocept, the correct procedure — not covered in the provided documents — is to (a) search the Secretary of State business‑entity database for the state where Neurocept is likely formed, (b) request the entity’s Statement of Information, annual report or Certificate of Status, or (c) if Neurocept were a public company, review its SEC filings and investor relations pages for officer lists; the supplied sources demonstrate how investor IR pages host SEC filings for named companies and how state SOS sites hold entity filings [1] [5] [6].
5. Tools and vendors that can speed the search — and what their listings mean
Commercial filing services offer to form entities and act as registered agents and can help retrieve filings across all states; these services also advertise options to limit public exposure of private information, which is relevant because in some cases officers or owners may use nominee agents or privacy services that complicate direct identification [7].
6. A note on interpreting officer and owner designations in filings
Corporate filings use standard roles — directors and officers (president, secretary, treasurer) — and the SEC and legal guides describe how executive officers are defined for disclosure purposes; locating a listed officer in a Statement of Information or Form 10‑K is normally sufficient to answer the user’s query, but such determination requires the specific filing which is not present in the supplied material [8] [9].
7. Conclusion: reporting gap and recommended action
Given the absence of any Neurocept‑specific filing in the provided dataset, no registered owner or corporate officer can be named here from these materials; the only responsible next step is to consult state Secretary of State records for the jurisdiction of incorporation or, if relevant, the SEC EDGAR database or the company’s investor relations page — methods supported by the sources cited but not exemplified for Neurocept itself [5] [1].